Company

SoftSeal®-STF is a hemostatic pad produced by Chitogen Inc. Chitogen is a medical device company dedicated to the development of next generation proprietary hemostatic products for the control of severe bleeding. Chitogen has a patented unique and versatile technology platform that will be developed into a number of differentiated products.

Hemostatic products are used in a wide range of applications and Chitogen is focusing on non-absorbable topical products to control bleeding for arterial puncture sites (primarily cardiac catheterizations) and hemodialysis treatment.

Steven Muellerleile

PRESIDENT & CEO

Steven Muellerleile has had a long and distinguished career in the healthcare industry. Mr. Muellerleile has a BS and MS degree from St Cloud State University and an MBA from the University of Minnesota. He served in the U.S. Marine Corps 9th District Reserve Infantry Division.

DOUGLAS EAYRS

CHIEF FINANCIAL OFFICER

Mr. Eayrs is a Chartered Financial Analyst (CFA) and a member of the CFA Institute and the Twin Cities Society of Securities Analysts. Mr. Eayrs received an MA degree from Marquette University and a BA degree from the University of Minnesota.

ROBERT LEVY, D.O., MBA

CHAIRMAN OF THE BOARD OF DIRECTORS

Dr. Levy is Board Certified by and a diplomate of the American College of Healthcare Executives (ACHE), a Certified Physician Executive by the American College of Physician Executives, and a registered financial consultant. He earned his Doctor of Osteopathy from the University of Osteopathic Medicine and Health Sciences (UOMHS) and his MBA from Duke University.

JAMES DRAKE, PH.D.

DIRECTOR AND CHIEF TECHNOLOGY OFFICER

Dr. Drake has held several senior positions including Founder and Chief Scientist for Medafor, Inc. He received his Ph.D. from the University of Minnesota specializing in Microbiology and Biochemistry.

TOM RITTER, PH.D.

VICE PRESIDENT OF OPERATIONS

Dr. Ritter has been a VP for R&D at Mentor Corporation and Director of Technology Development at Johnson & Johnson. Dr. Ritter received his Ph.D. in Metallurgy and Biomaterials Science from the University of Pennsylvania, an MBA from the University of Connecticut and BS in Metallurgical Engineering from Polytechnic Institute of Brooklyn.

YONG HUA ZHU, M.D.

DIRECTOR

Dr. Zhu is a retired Assistant Research Professor at Loma Linda University and is a co-inventor of the STF fiber. He has served as a consultant for Johnson & Johnson and Covidien. Dr. Zhu is a graduate from Shanghai Medical College with the specialty of neurosurgery.

FRED ALBRIGHT, MBA

DIRECTOR

Mr. Albright currently leads a consulting practice at a global management consulting firm. He possesses an MBA from Duke University and a BA in Economics from UCLA. Additionally, he is a California CPA (inactive status).